For healthcare professionals only


In brief

BMJ 2005; 330 doi: (Published 28 April 2005) Cite this as: BMJ 2005;330:982

Epilepsy drug trials to be reviewed: The US Food and Drugs Administration is calling on all manufacturers of epilepsy drugs to review their trial databases to see whether any possible link with suicide is shown. The call comes after claims by the New York personal injury lawyers Finkelstein and Partners that gabapentin (Neurontin), a Pfizer product that …

View Full Text

Log in

Log in through your institution


* For online subscription